Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1984 1
1985 2
1986 3
1987 1
1989 1
1990 2
1991 3
1992 6
1993 4
1994 1
1995 2
1997 11
1998 2
1999 6
2000 7
2001 8
2002 9
2003 5
2004 13
2005 15
2006 26
2007 18
2008 24
2009 31
2010 34
2011 34
2012 47
2013 65
2014 61
2015 65
2016 86
2017 98
2018 88
2019 105
2020 117
2021 155
2022 160
2023 139
2024 55

Text availability

Article attribute

Article type

Publication date

Search Results

1,308 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Dissociative, 2Ftherapy, 5BMeSH
Page 1
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies.
Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF. Palmer S, et al. Kidney Int. 2013 Jul;84(1):179-91. doi: 10.1038/ki.2013.77. Epub 2013 Mar 13. Kidney Int. 2013. PMID: 23486521 Free article. Review.
Prevalence estimates of depression in chronic kidney disease (CKD) vary widely in existing studies. We conducted a systematic review and meta-analysis of observational studies to summarize the point prevalence of depressive symptoms in adults with CKD. ...Estimated prevale …
Prevalence estimates of depression in chronic kidney disease (CKD) vary widely in existing studies. We conducted a systematic review …
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Aldred J, et al. Neurol Ther. 2023 Dec;12(6):1937-1958. doi: 10.1007/s40120-023-00533-1. Epub 2023 Aug 26. Neurol Ther. 2023. PMID: 37632656 Free PMC article.
INTRODUCTION: Foslevodopa/foscarbidopa, a soluble formulation of levodopa/carbidopa (LD/CD) prodrugs for the treatment of Parkinson's disease (PD), is administered as a 24-hour/day continuous subcutaneous infusion (CSCI) with a single infusion site. ...Secondary endpoints …
INTRODUCTION: Foslevodopa/foscarbidopa, a soluble formulation of levodopa/carbidopa (LD/CD) prodrugs for the treatment of Parkinson's dis …
[Asthenic post-COVID syndrome].
Khaibullina DK, Maksimov YN. Khaibullina DK, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(3):61-69. doi: 10.17116/jnevro202312303161. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 36946399 Russian.
Before the start of the study, in addition to a physical examination, the patient's condition was assessed using the following questionnaires and scales: VAS for asthenia, subjective scale for assessing asthenia (MFI-20), L.D. Malkova, a questionnaire for the quality of life (EQ- …
Before the start of the study, in addition to a physical examination, the patient's condition was assessed using the following questionnaire …
The effectiveness of sertraline in alleviating uremic pruritus in hemodialysis patients: a randomized clinical trial.
Elsayed MM, Elgohary IE, Abdelhamid HHS, Zaki SA. Elsayed MM, et al. BMC Nephrol. 2023 Jun 3;24(1):155. doi: 10.1186/s12882-023-03212-3. BMC Nephrol. 2023. PMID: 37270517 Free PMC article. Clinical Trial.
INTRODUCTION: Uremic pruritus (UP) is a common and distressing symptom in end stage renal disease (ESRD) patients. Many approaches have been tested to improve UP without a clear success. ...TRIAL REGISTRATION: ClinicalTrials.gov NCT05341843. First registration date: 22 …
INTRODUCTION: Uremic pruritus (UP) is a common and distressing symptom in end stage renal disease (ESRD) patients. Many approaches ha …
Subjective symptoms as predictors for eosinophilic chronic rhinosinusitis with nasal polyps in the Chinese population.
Zhang C, Wang H, Zhang Q, Chen J, Yu H, Li W, Xu H, Hu L, Wang D, Sun X. Zhang C, et al. Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3721-3729. doi: 10.1007/s00405-023-07905-1. Epub 2023 Mar 14. Eur Arch Otorhinolaryngol. 2023. PMID: 36917251
METHODS: A total of 102 patients with CRSwNP who underwent endoscopic sinus surgery were prospectively enrolled. The Sinonasal Outcomes Test-22 scores (SNOT-22), EuroQol 5-dimensional Questionnaire scores (ED-5D), and Lund-Mackay scores by computed tomography …
METHODS: A total of 102 patients with CRSwNP who underwent endoscopic sinus surgery were prospectively enrolled. The Sinonasal Outcomes Test …
Bilateral vestibulopathy: beyond imbalance and oscillopsia.
Lucieer FMP, Van Hecke R, van Stiphout L, Duijn S, Perez-Fornos A, Guinand N, Van Rompaey V, Kingma H, Joore M, van de Berg R. Lucieer FMP, et al. J Neurol. 2020 Dec;267(Suppl 1):241-255. doi: 10.1007/s00415-020-10243-5. Epub 2020 Oct 8. J Neurol. 2020. PMID: 33030608 Free PMC article.
In comparison to the qualitative results, quantitative data were collected using the Dizziness Handicap Inventory (DHI), Hospital Anxiety and Depression Scale (HADS) and a health-related quality of life questionnaire (EQ-5D-5L). RESULTS: Eighteen interviews were transcribe …
In comparison to the qualitative results, quantitative data were collected using the Dizziness Handicap Inventory (DHI), Hospital Anxiety an …
Temporal properties of positive and negative defocus on emmetropization.
Zhu X, Kang P, Troilo D, Benavente-Perez A. Zhu X, et al. Sci Rep. 2022 Mar 4;12(1):3582. doi: 10.1038/s41598-022-07621-6. Sci Rep. 2022. PMID: 35246571 Free PMC article.
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5D; OS: plano). Two control groups wore + 5D (n = 5) or - 5D (n = 13) lenses continuously for 9 h/day. ...Interrupting defo …
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5 …
Health utility reporting in chronic rhinosinusitis patients.
Bewick J, Morris S, Hopkins C, Erskine S, Philpott CM. Bewick J, et al. Clin Otolaryngol. 2018 Feb;43(1):90-95. doi: 10.1111/coa.12903. Epub 2017 Jun 13. Clin Otolaryngol. 2018. PMID: 28498517
Mean index score computed form the EQ-5D-5L was 0.75. Worse (higher) SNOT-22 scores were associated with lower EQ-5D-5L VAS and utility scores and SF-12 MCS and PCS scores. ...We found the SF-12 to be less sensitive and conclude that the EQ-5D-5L tool …
Mean index score computed form the EQ-5D-5L was 0.75. Worse (higher) SNOT-22 scores were associated with lower EQ-5D-5L …
The Disease Burden and Societal Costs of Hereditary Angioedema.
Fijen LM, Klein PCG, Cohn DM, Kanters TA. Fijen LM, et al. J Allergy Clin Immunol Pract. 2023 Aug;11(8):2468-2475.e2. doi: 10.1016/j.jaip.2023.03.032. Epub 2023 Mar 27. J Allergy Clin Immunol Pract. 2023. PMID: 36990433 Free article.
BACKGROUND: According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achieve total control of the disease and to normalize patients' lives. OBJECTIVE: This study aims to establish the entire burden of HAE com …
BACKGROUND: According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achiev …
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II).
Jamieson C, Canuso CM, Ionescu DF, Lane R, Qiu X, Rozjabek H, Molero P, Fu DJ. Jamieson C, et al. Qual Life Res. 2023 Nov;32(11):3053-3061. doi: 10.1007/s11136-023-03451-9. Epub 2023 Jul 13. Qual Life Res. 2023. PMID: 37439961 Free PMC article.
PURPOSE: To assess the effect of esketamine nasal spray on patient-reported outcomes (PROs) in patients with major depressive disorder having active suicidal ideation with intent (MDSI). METHODS: Patient-level data from two phase 3 studies (ASPIRE I; ASPIRE II) of esketami …
PURPOSE: To assess the effect of esketamine nasal spray on patient-reported outcomes (PROs) in patients with major depressive disorder …
1,308 results